Announcements Trials

Browse Landscape

Status

Unknown 9 Recruiting 6 Active not recruiting 6 Withdrawn 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Cyclophosphamide 391 Carboplatin 345 pembrolizumab 332 Gemcitabine 332 Cisplatin 328 Paclitaxel 298 Radiotherapy 297 Docetaxel 288 Bevacizumab 254 Rituximab 234 Capecitabine 224 Nivolumab 222 Dexamethasone 206 Fluorouracil 191 fludarabine 178 Oxaliplatin 178 Pemetrexed 154 Doxorubicin 153 Irinotecan 149 Leucovorin 145 Etoposide 144 Cytarabine 134 Cetuximab 131 fludarabine phosphate 129 Bortezomib 129 Lenalidomide 126 Erlotinib Hydrochloride 121 Filgrastim 120 Temozolomide 113 Radiosurgery 113

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Biopsy, Large-Core Needle × Clear all

NCT05435352 2025-07-30

PEAR-TNBC

Ourotech, Inc.

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡